Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial
Author(s) -
Kyeong Ho Yun,
SeungYul Lee,
Byung Ryul Cho,
Woo Jin Jang,
Young Bin Song,
Ju Hyeon Oh,
Woo Jung Chun,
Yong Hwan Park,
EulSoon Im,
JinOk Jeong,
Seok Kyu Oh,
DeokKyu Cho,
JongYoung Lee,
Young Youp Koh,
JangWhan Bae,
Jae Woong Choi,
Wang Soo Lee,
HyuckJun Yoon,
Seung Uk Lee,
Jang Hyun Cho,
Woong Choi,
SeungWoon Rha,
Joo Myung Lee,
Taek Kyu Park,
Jeong Hoon Yang,
JinHo Choi,
SeungHyuck Choi,
Sang Hoon Lee,
HyeonCheol Gwon,
JooYong Hahn,
DongBin Kim,
Sang Cheol Cho,
SunHo Hwang,
Dong Woon Jeon,
Jae Kean Ryu,
MooHyun Kim,
InHo Chae,
SangHyun Kim,
HackLyoung Kim,
DongKyu Jin,
Il Suh,
JongSeon Park,
EunSeok Shin,
ShinJae Kim,
SangSig Cheong,
Kyeong Ho,
Sung Yun Lee,
Jei Keon Chae,
Yong Yang,
JoonHyouk Choi
Publication year - 2020
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.120.018366
Subject(s) - medicine , percutaneous coronary intervention , sirolimus , stent , hazard ratio , post hoc analysis , myocardial infarction , drug eluting stent , population , surgery , conventional pci , cardiology , confidence interval , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom